HOME
PRODUCTS
Antibody
Primary Antibody
Second Antibody
Labeling Antibody
ELISA Kit
Micro Fast ELISA Kits
High Sensitive ELISA Kits
Fast Step ELISA Kit
Human ELISA Kits
Mouse ELISA Kits
Rat ELISA Kits
Other ELISA Kits
ELISA Auxiliary Reagent
Biochemical Analysis
Cell Function Reagents
Biochemical Assay
Exosome Kit
Recombinant Protein
Cytokine
Immunology Related Reagents
Western Blotting
Immunohistochemistry
Protein Marker
TECHNOLOGY
Publications
Signaling Pathway
FAQ
Discussion
NEWS CENTER
Company News
Bio Industry News
Product Brochure
Downloads
ABOUT US
Company Information
Join us
Contact us
CONTACT&PURCHASE
Contact&Purchase
Sales Promotion
All Categories
Primary Antibody
Second Antibody
Labeling Antibody
Human ELISA Kits
Mouse ELISA Kits
Rat ELISA Kits
Other ELISA Kits
ELISA Auxiliary Reagent
Cell Function Reagents
Biochemical Assay
Exosome Kit
Cytokine
Western Blotting
Immunohistochemistry
Protein Marker
Micro Fast ELISA Kits
High Sensitive ELISA Kits
Fast Step ELISA Kit
HOME
PRODUCTS
Antibody
Primary Antibody
Second Antibody
Labeling Antibody
ELISA Kit
Micro Fast ELISA Kits
High Sensitive ELISA Kits
Fast Step ELISA Kit
Human ELISA Kits
Mouse ELISA Kits
Rat ELISA Kits
Other ELISA Kits
ELISA Auxiliary Reagent
Biochemical Analysis
Cell Function Reagents
Biochemical Assay
Exosome Kit
Recombinant Protein
Cytokine
Immunology Related Reagents
Western Blotting
Immunohistochemistry
Protein Marker
TECHNOLOGY
Publications
Signaling Pathway
FAQ
Discussion
NEWS CENTER
Company News
Bio Industry News
Product Brochure
Downloads
ABOUT US
Company Information
Join us
Contact us
CONTACT&PURCHASE
Contact&Purchase
Sales Promotion
TECHNOLOGY
Publications
Signaling Pathway
FAQ
Discussion
Effects of porang glucomannan combined with a high-protein diet on oxidative stress, inflammation, and aging markers in D-galactose-induced rats
Publish:2025-05-20
Source:ReedBiotech
Views:14
PREV:Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial
NEXT:Oral colon-targeted delivery of recombinant human MANF for alleviation of ulcerative colitis